Delivery Order SPE2DB24D1007-SPE2DB25FBZUF

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $28,022.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract provides a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The current delivery order...
This federal contract award, valued at $19,543.78, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566348598 - Dapagliflozin 10 mg Tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $55,796.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566824454 - DAPAGLIFLOZIN 10 MG TABLET 30S, with a period of performance through January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.46 firm fixed-price delivery order is for the supply of 4,565,548,469 tablets of the drug Dapagliflozin 10 mg, with a period of performance through August 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Dapagliflozin 5 mg tablets to the government. The $22,292.73 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dapagliflozin 5 mg tablets. The award, valued at $7,676.67, is a firm fixed-price delivery order contract with a completion date of September 4, 2024. The contract is not set aside for a particular business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,741.99, is a delivery order for the supply of Dapagliflozin 10 mg tablets. It has a firm fixed price and an ultimate completion date of August 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,505.47, is for the delivery of Dapagliflozin 5 mg tablets. The contract is a firm fixed-price Delivery Order with a completion date of May 29, 2024. No set-aside designation was used for this contract award. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,006,611 units of the medication dapagliflozin 10 mg tablets. The firm-fixed-price delivery order, valued at $9,452.28, has a completion date of June 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FBZUF
    Delivery Order

This federal contract award, valued at $3,374.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The specific contract award is for the delivery of 4566831501 - Dapagliflozin 5 mg Tablets, with a completion date of January 6, 2025. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 4/4/25, 10:00 AM